Peripheral artery disease hair loss — specifically the gradual thinning or disappearance of hair on the lower legs and feet — is a clinically recognised sign of reduced arterial blood flow to the limbs. Caused primarily by atherosclerosis, peripheral artery disease (PAD) restricts the delivery of oxygen and nutrients to peripheral tissues, including the hair follicles that depend on this supply to sustain normal growth. Whilst leg hair loss alone is not diagnostic, it can be an early and important indicator of underlying vascular disease, particularly when accompanied by other symptoms. This article explains the mechanism, associated signs, when to seek help, and how PAD is diagnosed and managed on the NHS.

Why Peripheral Artery Disease Can Cause Hair Loss on the Legs

PAD reduces arterial blood flow to the lower limbs, depriving hair follicles of oxygen and nutrients, causing them to become dormant — resulting in patchy hair loss most pronounced on the shins, ankles, and feet.

Not sure if this is normal? Chat with one of our pharmacists →

Peripheral artery disease (PAD) is a common circulatory condition in which narrowed arteries reduce blood flow to the limbs, most often the legs. It is primarily caused by atherosclerosis — the build-up of fatty plaques within arterial walls — which progressively restricts the delivery of oxygen and nutrients to peripheral tissues. One of the lesser-discussed but clinically recognised consequences of this reduced perfusion is hair loss on the lower legs and feet.

Hair follicles are metabolically active structures that depend on a consistent supply of oxygenated blood to sustain their growth cycles. When arterial blood flow is chronically compromised, follicles in the affected limb can enter a prolonged resting phase or become permanently dormant. This results in a gradual thinning or complete absence of leg hair — a sign that clinicians often look for during physical examination as part of a broader assessment of limb perfusion. The pattern of hair loss is typically patchy and most pronounced distally, affecting the shins, ankles, and feet.

It is important to note that leg hair loss alone is not diagnostic of PAD. Common non-vascular causes include normal ageing, friction from clothing or footwear, hormonal changes, and dermatological conditions. However, in the context of other vascular symptoms — particularly in people with established cardiovascular risk factors — unexplained distal leg hair loss serves as a useful clinical indicator. The NHS and NICE Clinical Knowledge Summary (CKS) on peripheral arterial disease list hair loss on the legs and feet among the recognised signs of PAD. Patients who notice unexplained hair loss on their lower legs, particularly if accompanied by other symptoms, should discuss this with their GP, as it may warrant further investigation.

How Reduced Blood Flow Affects Skin and Hair Follicles

Reduced perfusion causes hair follicles to prematurely enter the resting phase and eventually atrophy, producing localised alopecia alongside other skin changes such as shiny taut skin, slow-healing wounds, and thickened toenails.

The skin and its appendages — including hair follicles, sweat glands, and sebaceous glands — are highly sensitive to changes in local blood supply. In PAD, the progressive narrowing of peripheral arteries means that tissues in the lower limbs receive insufficient oxygen and nutrients. Over time, this chronic reduction in perfusion has a measurable impact on the structural integrity and function of the skin.

Hair follicles require adequate microvascular perfusion to support the anagen (active growth) phase of the hair cycle. When perfusion is reduced, follicles may prematurely shift into the telogen (resting) phase, leading to hair shedding without subsequent regrowth. In more advanced cases of PAD, follicles may atrophy entirely, resulting in permanent, localised alopecia on the shins, ankles, and dorsum of the feet.

Beyond hair loss, reduced blood flow causes a range of visible skin and nail changes:

• Skin pallor or a dusky, mottled appearance, particularly when the leg is elevated

• Shiny, taut skin that appears thin and fragile

• Dry, scaly skin, which may in part reflect reduced sweat and sebaceous gland function associated with impaired perfusion

• Slow-healing wounds or ulcers, especially around the toes and heels

• Thickened, discoloured, or brittle toenails that may grow more slowly than usual

These changes collectively reflect the skin's vulnerability when its blood supply is compromised. It is important to use precise terminology: the term critical limb ischaemia should be reserved for the most severe stage of PAD, characterised by rest pain, ulceration, or gangrene. Recognising early skin and hair changes is important, as they can precede this more serious stage and prompt timely vascular assessment (NICE CG147).

Other Symptoms of Peripheral Artery Disease to Be Aware Of

The most characteristic PAD symptom is intermittent claudication — cramping leg pain on exertion relieved by rest — alongside cold feet, colour changes, weak pulses, and non-healing ulcers.

Hair loss on the legs is just one of several signs that may indicate underlying peripheral artery disease. The condition presents across a spectrum of severity, and symptoms often develop gradually, which means many people attribute early warning signs to normal ageing or other benign causes.

The most characteristic symptom of PAD is intermittent claudication — a cramping pain, aching, or heaviness in the calf, thigh, or buttock that occurs during walking or physical exertion and is relieved by rest. This pain arises because exercising muscles demand more oxygen than the narrowed arteries can supply. As the disease progresses, symptoms may occur at rest, particularly at night, when the legs are elevated and gravity no longer assists blood flow.

Other symptoms to be aware of include:

• Cold or numb feet and toes, even in warm conditions

• Weak or absent pulses in the feet or ankles

• Colour changes in the legs — pallor on elevation, redness (rubor) on dependency

• Erectile dysfunction in men, which may be an early indicator of systemic atherosclerosis affecting pelvic and lower limb vessels

• Non-healing sores or ulcers on the feet, toes, or lower legs

• Gangrene in severe, untreated cases

It is worth noting that a significant proportion of people with PAD are asymptomatic or have atypical symptoms — such as reduced walking speed or non-specific exertional leg discomfort — which can delay diagnosis. Older adults in particular may limit their activity to avoid symptoms, masking the condition. Risk factors — including smoking, type 2 diabetes, hypertension, hypercholesterolaemia, and a history of cardiovascular disease — should heighten clinical suspicion even in the absence of classic claudication (NICE CG147; NICE CKS: Peripheral arterial disease).

When to Seek Medical Advice from Your GP or Vascular Team

See your GP promptly for exertional leg pain, unexplained leg hair loss, or slow-healing foot wounds; call 999 immediately for sudden severe leg pain, pallor, pulselessness, or paralysis, which indicate acute limb ischaemia.

Knowing when to seek medical advice is essential for preventing PAD from progressing to more serious complications. Many people delay consulting their GP because they assume leg pain or skin changes are simply a consequence of ageing. However, early assessment and intervention can significantly reduce the risk of limb loss and major cardiovascular events such as heart attack and stroke.

You should contact your GP promptly if you notice:

• Leg pain, cramping, or heaviness that consistently occurs during walking and resolves with rest

• Unexplained hair loss on the lower legs, particularly alongside other skin changes

• Persistent coldness, numbness, or colour changes in one or both feet

• A wound, sore, or ulcer on the foot or lower leg that is slow to heal or not healing at all — seek urgent review if you have diabetes, as infection and tissue loss can escalate rapidly

Seek emergency assessment immediately (call 999 or go to A&E) if you develop any of the following, as these may indicate acute limb ischaemia — a vascular emergency:

• Sudden severe leg pain

• Pallor or a white/blue discolouration of the limb

• Pulselessness or a limb that feels perishingly cold

• Pins and needles (paraesthesia) or loss of sensation

• Weakness or inability to move the foot or leg (paralysis)

If you are already known to have PAD and your symptoms worsen — for example, pain occurring at shorter walking distances or beginning at rest — contact your GP or vascular team without delay. Similarly, any new skin breakdown or ulceration in a person with known PAD warrants urgent review.

People with established cardiovascular risk factors, particularly smokers and those with diabetes, should be especially vigilant and proactive in reporting new lower limb symptoms, even if they seem minor (NICE CG147; NICE CKS: Peripheral arterial disease).

Diagnosis and Assessment: What to Expect on the NHS

Diagnosis begins with clinical examination and an ankle-brachial pressure index (ABPI) measurement; an ABPI of 0.90 or below confirms PAD, with duplex ultrasound or angiography used if revascularisation is being considered.

If PAD is suspected, your GP will begin with a thorough clinical history and physical examination. This includes assessing your cardiovascular risk factors, examining the skin and hair distribution on your legs, checking for pulses in the feet and ankles, and listening for arterial bruits (abnormal sounds caused by turbulent blood flow through narrowed vessels).

The cornerstone of PAD diagnosis in primary care is the ankle-brachial pressure index (ABPI) — a simple, non-invasive test that compares blood pressure measured at the ankle with that measured at the arm. NICE guidance (CG147) recommends ABPI measurement as the first-line investigation for suspected PAD. An ABPI of 0.91–1.00 is borderline; a value of 0.90 or below is generally considered abnormal and indicative of PAD. An ABPI above 1.3 may suggest arterial calcification (non-compressible vessels) and should not be interpreted as normal.

Importantly, ABPI can be unreliable in people with diabetes or chronic kidney disease, whose arteries may be calcified and incompressible. In these cases, a toe-brachial index (TBI) or toe pressure measurement — which uses digital arteries less prone to calcification — may be a more appropriate alternative, and referral to a vascular laboratory should be considered.

Depending on the results and clinical picture, further investigations may include:

• Duplex ultrasound — to visualise arterial anatomy and identify sites of stenosis or occlusion

• CT angiography or MR angiography — for detailed vascular mapping, primarily when revascularisation is being planned rather than as a routine investigation

• Blood tests — including fasting glucose, HbA1c, lipid profile, full blood count, and renal function

Referral to a vascular surgery team is recommended for patients with severe or progressive symptoms, rest pain, or tissue loss. The NHS vascular pathway aims to ensure timely access to specialist assessment, and most patients with significant PAD will be managed within a multidisciplinary team that includes vascular surgeons, specialist nurses, podiatrists, and diabetes teams where appropriate (NICE CG147; NICE CKS: Peripheral arterial disease).

Managing Peripheral Artery Disease and Its Effect on Skin Health

PAD management combines smoking cessation, supervised exercise, antiplatelet therapy (clopidogrel 75 mg daily), and high-intensity statins; good foot care and daily skin inspection are essential to prevent ulceration.

Management of PAD is aimed at reducing cardiovascular risk, improving walking capacity, relieving symptoms, and preserving limb integrity. NICE guidance (CG147) recommends a structured approach combining lifestyle modification, pharmacological therapy, and — where necessary — revascularisation procedures.

Lifestyle measures form the foundation of PAD management and include:

• Smoking cessation — the single most effective intervention for slowing disease progression; NHS Stop Smoking Services offer evidence-based support

• Supervised exercise therapy — NICE recommends a structured programme of at least two hours per week for a minimum of three months, incorporating walking to near-maximal pain tolerance, which has been shown to improve walking distance and quality of life

• Dietary modification — a heart-healthy diet low in saturated fat and high in fruit, vegetables, and wholegrains

• Blood pressure and blood glucose control — particularly important in patients with hypertension or diabetes

Pharmacological treatment for symptomatic PAD typically includes:

• Antiplatelet therapy: Clopidogrel 75 mg once daily is the preferred first-line antiplatelet agent for people with symptomatic PAD, in line with NICE CG147. Low-dose aspirin (75 mg daily) may be used if clopidogrel is not tolerated. Antiplatelet therapy is not routinely recommended for people with asymptomatic PAD.

• High-intensity statin therapy: Atorvastatin 80 mg daily is recommended for people with established cardiovascular disease, including PAD, unless contraindicated, in line with NICE guidance on lipid modification (NG238).

• Antihypertensive and glucose-lowering medications are adjusted as needed to meet individual targets.

• Naftidrofuryl oxalate is a pharmacological option for people with intermittent claudication in whom supervised exercise has not led to satisfactory improvement and who are not suitable for revascularisation (NICE CG147).

• Rivaroxaban 2.5 mg twice daily in combination with aspirin 75–100 mg daily may be considered in selected adults with symptomatic PAD who are at high cardiovascular risk and low bleeding risk. This is a specialist-initiated treatment, in line with NICE Technology Appraisal TA607.

For skin and hair health specifically, good foot and leg care is essential. Patients should be advised to:

• Inspect their feet and lower legs daily for cuts, blisters, or colour changes

• Moisturise dry skin regularly to prevent cracking

• Avoid extremes of temperature, tight footwear, and going barefoot

• Attend regular podiatry reviews, particularly if they have diabetes

Whilst hair regrowth on the legs is unlikely unless blood flow is substantially restored through revascularisation, improving overall perfusion through the above measures can help preserve skin integrity and reduce the risk of ulceration. Patients should view leg hair loss not as a cosmetic concern, but as a prompt to engage proactively with their vascular health.

Frequently Asked Questions